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Racial differences in survival of patients on dialysis. tality rate (adjusted for age, gender, and renal disease
Background. Recent studies have documented racial differ- diagnosis) in Caucasian patients was consistently higher
ences in the crude mortality rates of patients on dialysis. How- than black patients and patients from the Asia-Pacificever, proper interpretation of these findings requires adjust-
regions [1, 2]. Similarly, the crude mortality rate of hemo-ment for potential confounders and comorbid risk factors
dialysis patients in the age range of 45 to 54 years was 5between the racial groups.
Methods. We examined the clinical data on 3752 Caucasian to 10% higher in Europe than in Japan [3, 4]. However,
patients, 451 Southeast Asian patients, 322 South Asian pa- without adjusting for differences in dialysis accessibility
tients, and 319 black patients who were treated with hemodialy- and other comorbid risk factors for survival betweensis or peritoneal dialysis under a Universal Health Care system
racial groups, proper interpretation of these findings re-in Toronto and prospectively followed between 1981 and 1995.
mains uncertain.In all patients, a number of comorbid risk factors for survival
was assessed at the start of dialysis and was reassessed with Treatment of ESRD in Canada consists of a compre-
their outcome status (that is, continued dialysis, transplanta- hensive and integrated system of government-funded pro-
tion, death, or loss to follow-up) at least every six months. grams in hemodialysis, peritoneal dialysis, and renal trans-Cox proportional hazards analysis was used to fit multivariate
plantation, which is universally accessible to all Canadiansmodels predicting patient survival. Pairwise comparisons of
[5]. Since 1981, the Toronto Regional Dialysis Registrythe relative hazards of death between the racial groups were
performed after stratifying for cardiovascular disease, diabetes has been collecting data on demographics and comorbid
mellitus, and hypertension at the start of dialysis, and were risk factors in all patients at start of their ESRD treat-
adjusted for differences in other comorbid risk factors. ment program (Methods section). This database reflectsResults. The risk of death in Caucasian patients was signifi-
a regional experience of a population of 4.5 million, ascantly increased when compared with Southeast Asian patients,
well as a diverse mixture of ethnic groups (that is, 80%South Asian patients, and black patients [multivariate relative
hazards (95% CI): 1.63 (1.36 to 1.97), 1.36 (1.07 to 1.73), 1.34 Caucasian, 10% Southeast Asian, 5% South Asian, and
(1.07 to 1.67), respectively]. Additionally, we detected an inter- 5% blacks) unique to the Metropolitan Toronto area [6].
action between race and cigarette smoking (P , 0.004), sug-
gesting that in the dialysis patients who smoked, whites had a
higher mortality risk compared with non-whites. METHODS
Conclusions. Differences in patient survival on dialysis exist
Study design and data collectionbetween racial groups. However, the genetic and environmen-
tal determinants that underlie these differences are presently This is a prospective cohort study. Since January of
unknown.
1981, the Toronto Regional Dialysis Registry has docu-
mented a number of demographic and comorbid risk
factors in all patients at start of their ESRD treatment
Recent data from several end-stage renal disease
program. They include age, gender, race, dialysis mod-
(ESRD) registries have documented racial differences
ality; dialysis start year; and ESRD diagnosis. Addition-in the crude mortality rates of patients on dialysis [1–4].
ally, all patients were assessed for a history of cigaretteFor example, data from the United States Renal Data
smoking; hypertension; diabetes mellitus; symptomaticSystem indicated that between 1980 and 1994, the mor-
coronary, cerebral, or peripheral vascular disease; con-
gestive heart failure; chronic respiratory disease; malig-
nancy; and any serious illness that may shorten life expec-Key words: cardiovascular disease, race, hemodialysis, end-stage renal
disease, renal failure, peritoneal dialysis. tancy to less than five years. The latter comorbid risk
factors were reassessed with the patient outcome statusReceived for publication November 29, 1999
(that is, continued dialysis treatment, death, transplanta-and in revised form April 7, 2000
Accepted for publication April 14, 2000 tion, or loss to follow-up) every six months up to June
of 1989 and then at monthly intervals thereafter.Ó 2000 by the International Society of Nephrology
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Patient classification and selection survival without using any race information, race indica-
tors were added to the model, and interactions betweenAll patients were classified under five major racial
race and the risk factors were examined by using stepwisegroupings: (1) Caucasian (white); (2) Southeast Asian
selection. The starting model included the main effects(including patients of Chinese, Japanese, Korean, and
(including race), all the two-way risk factor interactionsIndo-Chinese origins); (3) South Asian (including pa-
identified in the forward selection, and all interactionstients of East Indian, Pakistani, and Punjabi origins);
between white race and the other risk factors. The main(4) black (including black patients from Africa and the
effects, such as age, gender, and previously identifiedCaribbean); and (5) others (including patients of Aborig-
interactions, were not allowed to leave the model. Third,inal, Arabic, Hispanic, Polynesian, mixed, or unknown
the effect of renal transplantation on these relative haz-ethnic origins). All patients assessed between January
ards was also investigated. A model with a time-depen-1981 and June 1995 were included in the analysis, except
dent covariate for transplant status investigated interac-those who died within the first three months of dialysis,
tions between race and transplant. Also, a multivariatethose who received a renal allograft without ever being
model predicting time to death post-transplantation wasdialyzed, and those who belonged to the “other” racial
fit. There were many fewer deaths post-transplantationgroup (that is, ,4% of all patients).
so that model fitting for these data was simpler. This
model was stratified by cardiovascular disease and diabe-Statistical analysis
tes mellitus only, because of a very small number ofAll data are expressed as mean 6 SD or percentages
deaths in some strata when hypertension was includedand were compared between the four racial groups using
as a third stratification variable. Only a few covariatesone-way analysis of variance (ANOVA) for continuous
were included as predictors. We also modeled the totalvariables and contingency table analysis for binary vari-
follow-up time, including a time-dependent variable forables. Only one overall P value is given for these descrip-
transplantation status, and examined interactions be-tive data to indicate whether there are differences among
tween this indicator, race, and other variables.
the racial groups. Patient survival for the four racial
To examine the relationships between smoking and
groups was estimated as a function of time by the underlying cardiovascular disease to the overall risk of
Kaplan–Meier method, with patient follow-up censored deaths further, models were also fit to two subgroups:
at renal transplantation [7]. patients with and without cardiovascular disease at the
The Cox proportional hazards analysis was used to fit start of dialysis. The same modeling approach as that
multivariate models predicting survival and to obtain previously mentioned was applied, first examining all
multivariate relative hazards of death between the racial predictors but race, then including the race indicators
groups [8]. All demographic and comorbid risk factors and interactions, and finally exploring the effects of
collected as well as a composite index of cardiovascular transplantation.
disease severity (NRISK: 0 to 4 with the presence of
angina, myocardial infarction, symptomatic peripheral,
RESULTSor cerebral vascular disease at start of dialysis each
scored one point) were tested for a linear effect on sur- Patient characteristics by racial groups
vival and used in the analysis (Methods section). Overall, 30% of the patient cohort remained alive on
Smoothed plots of martingale residuals showed that lin- dialysis; 21% were alive with a renal allograft; 43.5%
ear covariate effects for age, start year, and NRISK ade- died while on dialysis or after renal transplantation; and
quately fit the data [9]. The multivariate model fitting 5.5% were lost to follow-up at the end of the study
included three stages. First, to control for confounding period. A total of 26% of the patient cohort received a
caused by other risk factors, all available covariates and renal allograft during the study period. Tables 1 and 2
two-factor interactions, excluding race, were examined, show that a number of demographic and comorbid risk
but with patient follow-up censored at transplantation factors were different between the racial groups at start
at this step. Because of a lack of proportionality over of dialysis. For example, both Southeast Asian and white
time for the hazard of death between hypertensive and patients were older than South Asian and black patients.
nonhypertensive patients and to allow for maximum There were more males in white and South Asian pa-
flexibility in the baseline hazard, multivariate models tients than Southeast Asian and black patients. More
were stratified for three known risk factors: hyperten- Southeast Asian and South Asian patients were on peri-
sion, cardiovascular disease, and diabetes mellitus (all toneal dialysis treatment compared with whites and
at the start of dialysis). All main effects except race were blacks. The prevalence of diabetes mellitus was higher
forced into the model, and a forward selection approach in Southeast Asian, South Asian, and black patients than
was used to examine two-way interactions between risk white patients, reflecting an increased prevalence of type
II diabetes mellitus in the former racial groups. Of note,factors. Second, having chosen the best model predicting
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Table 1. Patient characteristics at start of dialysis
Caucasian Southeast Asian South Asian Blacks
(N 5 3752) (N 5 451) (N 5 322) (N 5 319) P value
Age years 56.5616 57.3617 52.7615 50.6615 ,0.0001
Age .65 years 36% 42% 22% 18% ,0.0001
Sex male:female 1.57 1.04 1.46 1.26 ,0.0003
Modality PD:HDa 1.80 2.47 2.22 1.55 ,0.005
Dialysis duration years 2.0361.93 2.2561.85 1.9161.56 2.3362.02 50.004
Total follow-upb years 3.4563.32 3.3663.06 3.0362.84 3.3463.07 50.16
History of smokingc 36% 16% 13% 23% ,0.0001
Coronary artery diseased 24% 14% 23% 17% ,0.0001
Vascular diseasee 21% 12% 13% 19% ,0.0001
Congestive heart failuref 26% 24% 28% 27% 50.56
Hypertension 73% 77% 81% 84% ,0.0001
Malignancy 7.5% 3% 3% 3% ,0.0001
Serious illnessg 3.6% 5.1% 3.4% 5.0% 50.26
a PD, peritoneal dialysis; HD, hemodialysis
b Total follow-up time since initiation of dialysis, including follow-up time after transplantation
c Ex- or current smoker
d Coronary artery disease (history of angina and/or myocardial infarction)
e Peripheral vascular disease (claudication or ischemic gangrene) or cerebral vascular disease (i.e., transient ischemic attack or stroke)
f Including pulmonary edema within 6 months of starting dialysis
g Serious illness limiting life expectancy to less than 5 years
Table 2. Primary diagnosis of end-stage renal disease
Caucasian Southeast Asian South Asian Blacks
(N 5 3752) (N 5 451) (N 5 322) (N 5 319)
Diabetes mellitus 27% 32% 38% 37%
Glomerulonephritis 21% 32% 25% 23%
Hypertension 11% 11% 11% 15%
Polycystic kidney disease 7% 1% 3% 5%
Miscellaneous 34% 24% 23% 20%
there was a higher prevalence of cardiovascular disease, The models were stratified by cardiovascular disease,
cigarette smokers (both ex-and current smokers), and hypertension, and diabetes mellitus, which all had large
malignancies in the white patients at start of dialysis effects on survival. For parameters estimated in the pro-
compared with the other racial groups. Table 3 shows the portional hazards regression, age, dialysis start year, ma-
major causes of deaths in the four racial groups, with lignancy, and congestive heart failure had the largest
and without censoring at renal transplantation. Overall, effects (in models with or without interactions), all with
2104 patients died during the study period, and 90.6% P values much less than 0.0001. In addition, most of the
of these deaths occurred during dialysis. In general, car- predictor variables were involved in multiple two-way
diovascular disease complications account for about half interactions, suggesting that these interactions identify
of the deaths in all racial groups. With the exception of a high-risk patient profile that no one variable can inde-
a lower percentage of death from withdrawal of treat- pendently capture.
ment in the black patients, there was no significant differ- Having chosen the best model predicting survival with-
ence in the percentages of death in each of the main out using any race information, race indicators were
causes of death between the racial groups. Figure 1 shows added to the model, and interactions between race and
the Kaplan–Meier survival curves of the four racial
the risk factors were identified by using stepwise selec-groups, showing all deaths that occurred during dialysis.
tion. The final models included the main effects (includ-Caucasian patients appeared to have the lowest survival
ing race), all of the two-way risk factor interactions iden-among the four racial groups. The overall crude mortality
tified in the forward selection, and all interactionsrate during dialysis in white patients compared with
between white race and the other risk factors. The mainSoutheast Asian, South Asian, and black patients was
effects, such as age, gender, and previously identified211 versus 128, 120, and 118 deaths per 1000 patient-
interactions, were not allowed to leave the model evenyears on dialysis, respectively.
if they were no longer significant at P , 0.05. All two-
Multivariate models predicting patient survival way interactions that entered each reported model are
listed in Tables 4 and 5. In a few cases, the P values forIn the best fitting models, all main effects except for
gender had substantial power to predict patient survival. the two-way interactions are greater than 0.05. This is
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Table 3. Causes of death of study patients
Caucasian Southeast Asian South Asian Blacks
Deaths during dialysisa (N 5 1614) (N 5 130) (N 5 74) (N 5 88)
Cardiovascularb 49% 48% 53% 56%
Sepsis 15% 15% 14% 15%
Withdrawal from treatment 13% 15% 10% 6%
Malignancy 7% 6% 5% 7%
Miscellaneous 16% 16% 18% 16%
Caucasian Southeast Asian South Asian Blacks
All deathsc (N 5 1787) (N 5 142) (N 5 83) (N 5 92)
Cardiovascularb 48% 47% 51% 57%
Sepsis 15% 14% 15% 14%
Withdrawal from treatment 13% 13% 10% 5%
Malignancy 7% 7% 5% 8%
Miscellaneous 17% 19% 19% 16%
a Excluding all deaths after renal transplantation in patients who received a renal allograft
b Myocardial infarction, peripheral or cerebral vascular disease
c Including all deaths during dialysis and after renal transplantation in patients who received a renal allograft
Fig. 1. Kaplan–Meier survival curves of pa-
tients from the four racial groups, with patient
follow-up censored at renal transplantation.
Symbols are: (———) white; (··········) South
Asian; (––– –) South East Asian; (- - - - -) black.
Caucasian patients had a lower overall sur-
vival rate compared with the other three racial
groups (P , 0.0001).
because the best model, which did not include the race tus. We found that white smokers had a significantly
increased hazard of death compared with smokers fromindicator, was founded before adding race and interac-
tions with other variables. Of interest, a significant inter- the three other racial groups. For nonsmokers, white
patients had a smaller but also increased hazard of deathaction between race and cigarette smoking was also de-
tected (P , 0.004; see also the next section). compared with patients from Southeast Asia and a trend
for increased hazards of death compared with the South
Relative hazards of death between racial groups Asian and black patients (Table 4). Because the sample
size in the non-white racial groups was relatively small,From the multivariate analyses, we derived pairwise
relative hazards of death between the four racial groups. we were unable to determine whether there was any
difference in the relative hazards of death between theseThere was no evidence that the relative hazard of death
associated with race changed with time. We found that racial groups (data not shown).
We also addressed a potential concern that our find-white patients had an increased hazard of death during
dialysis when compared with the three other racial ings might have been attributed to a bias in which a
higher proportion of healthy Caucasians relative to thegroups (Table 4). Since a significant interaction between
race and cigarette smoking had been detected, we also other racial groups was selected for renal transplanta-
tion. Such a bias could have led to a larger pool ofexamined the relative hazards of death by smoking sta-
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Table 4. Relative hazards of death in study patients by racial groups
Overall Nonsmoker Smoker
Death censored at renal transplantationa
Caucasian vs. Southeast Asian 1.63 (1.36–1.97) 1.51 (1.24–1.83) 2.64 (1.75–3.98)
Caucasian vs. South Asian 1.36 (1.07–1.73) 1.24 (0.97–1.58) 2.16 (1.45–3.23)
Caucasian vs. black 1.34 (1.07–1.67) 1.16 (0.92–1.47) 2.04 (1.39–2.97)
Caucasian vs. all 1.47 (1.29–1.68) 1.34 (1.16–1.55) 2.26 (1.60–3.18)
Death post-transplantationa,b
Caucasian vs. Southeast Asian 1.12 (0.62–2.04)
Caucasian vs. South Asian 1.04 (0.53–2.04)
Caucasian vs. black 2.44 (0.90–6.61)
Caucasian vs. all 1.30 (0.85–1.99)
a Relative hazards (95% CI) from Cox proportional hazards analysis stratified for cardiovascular disease, diabetes mellitus, and hypertension at start of dialysis
and adjusted for all the main effects (age, gender, dialysis modality, dialysis start-year, serious illness at start of dialysis, cigarette smoking, malignancy, congestive
heart failure, chronic obstructive lung disease, NRISK) and the following two-way interactions, all with P , 0.05 (hypertension 3 smoking; age 3 diabetes mellitus;
diabetes mellitus 3 smoking; cardiovascular disease 3 malignancy; age 3 chronic obstructive lung disease; age 3 serious illness at start of dialysis; age 3 malignancy;
age 3 NRISK; dialysis modality 3 serious illness at start of dialysis; dialysis start year 3 smoking; serious illness at start of dialysis 3 NRISK).
b Deaths post-transplantation only in all patients who received a renal allograft. Analysis is stratified for cardiovascular disease, diabetes mellitus, and hypertension
at start of dialysis, and adjusted for age, gender, transplant year, and malignancy.
Table 5. Relative hazardsa of death in study patients with or without clinical cardiovascular disease at initiation of dialysis
Death censored at renal transplantation
cPresented with
cardiovascular diseasebPresented without
cardiovascular disease Nonsmoker Smoker
Caucasian vs. Southeast Asian 1.79 (0.43–2.26) 1.20 (0.86–1.68) 2.39 (1.42–4.02)
Caucasian vs. South Asian 1.33 (0.94–1.88) 1.27 (0.90–1.80) 2.53 (1.49–4.28)
Caucasian vs. black 1.13 (0.85–1.51) 1.33 (0.91–1.93) 2.64 (1.63–4.26)
Caucasian vs. all 1.50 (1.26–1.79) 1.26 (1.00–1.59) 2.53 (1.62–3.92)
a Relative hazards (95% CI) from Cox proportional hazards analysis stratified for diabetes mellitus and hypertension at start of dialysis, and adjusted for all
covariates that predict survival
b For patients without cardiovascular disease at start of dialysis, the analyses were also adjusted for all the main effects as above, except NRISK and the following
two-way interactions (age 3 diabetes mellitus, P 5 0.00001; age 3 malignancy, P , 0.00001; hypertension 3 smoking, P , 0.005; age 3 serious illness at start of
dialysis, P , 0.006; diabetes mellitus 3 malignancy, P , 0.01; dialysis modality 3 chronic obstructive lung disease, P , 0.05; hypertension 3 gender, P , 0.05; age 3
chronic obstructive lung disease, P , 0.05; diabetes mellitus 3 dialysis start-year, P , 0.01; dialysis start-year 3 smoking, P , 0.05; hypertension 3 chronic obstructive
lung disease, P , 0.05)
c For patients with cardiovascular disease at start of dialysis, the analyses were also adjusted for all of the main effects (age, gender, dialysis modality, dialysis
start-year, serious illness at start of dialysis, cigarette smoking, malignancy, congestive heart failure, chronic obstructive lung disease, NRISK) and the following two-
way interactions (dialysis modality 3 serious illness at start of dialysis, P , 0.00001; diabetes mellitus 3 chronic obstructive lung disease, P , 0.025; chronic obstructive
lung disease 3 congestive heart failure, P , 0.02; hypertension 3 NRISK, P 5 0.078).
sicker white patients on dialysis, thus accounting for the disease at the start of dialysis. Table 5 shows that in
increased relative hazard of death among whites. A patients with symptomatic cardiovascular disease, white
model that included a time-dependent covariate for smokers had a significantly increased hazard of death
transplant status did not detect a significant change in compared with smokers from the other three racial
hazard with transplant for any racial group. Also, the groups. In contrast, for nonsmokers with or without
relative hazards of death post-transplantation in our symptomatic cardiovascular disease, there was a smaller
white patients were at or above unity compared with the and often nonsignificant trend for increased hazards of
other racial groups (Table 4). Taken together with the death in the white patients compared with the other
finding that only 9.4% of all deaths occurred after trans- racial groups. However, the overall relative hazard of
plantation (Results section), these data provide strong death for Caucasians versus all other racial groups did
evidence against a race-specific transplantation bias as not differ from the same racial comparison among pa-
an explanation for the increased relative hazards of death tients who presented without cardiovascular disease
in our white patients. (that is, 1.47 vs. 1.50, respectively; Tables 4 and 5).
To examine the relationship between cigarette smok-
ing and underlying cardiovascular disease to the overall
DISCUSSIONrisk of death further, a subgroup analysis was performed
Using a database that reflects the regional experienceto compare the hazards of death between the four racial
groups, with and without symptomatic cardiovascular of a universal healthcare treatment system for ESRD
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and a unique mixture of patients with different racial cardiovascular disease burden are not presently avail-
origins [5, 6], we have documented an increased mortality able. Similarly, racial differences in genetic susceptibility
risk during dialysis in white patients compared with three factors may underlie the biologic variability of human
other racial groups, after adjusting for differences in their disease traits such as cardiovascular disease complica-
comorbid risk factors. We have also excluded a potential tions [18]. In this context, a recent study has documented
concern that our findings might have been attributed to pharmacogenetic differences in nicotine metabolism be-
a bias in which a higher proportion of healthy whites tween black and white smokers and suggests a differen-
were selected for transplantation, thus leaving a rela- tial risk for addiction and other medical complications
tively larger pool of sicker white patients on dialysis. of cigarette smoking between these racial groups [20, 21].
Atherosclerosis is a frequent and important cause of In the current study, nonsmoking white patients also
morbidity and mortality for patients with ESRD [10–16]. had an increased hazard of death compared with South-
The notion that atherosclerosis is accelerated in the ure- east Asian patients and a trend for increased hazards of
mic milieu has been suggested [12–14] and is supported death compared with South Asian and black patients
by the documented 15- to 20-fold increase in cardiovas- (Table 4). Moreover, the overall hazard of death for
cular mortality in dialysis patients compared with age- whites versus all other racial groups did not differ from
and sex-matched populations without renal disease [10, the same comparison among patients without symptom-
11, 15]. Thus, it is not surprising that cardiovascular dis- atic cardiovascular disease at the start of dialysis (that
ease accounts for 50% of all deaths in the patients with is, 1.47 vs. 1.5, respectively). These findings suggest that
ESRD [11, 15, 16]. However, while a higher prevalence additional risk factors other than cigarette smoking and
of cardiovascular disease at the start of dialysis was noted cardiovascular disease may influence survival. Of inter-
in whites compared with other racial groups (Table 1), est, dialysis dose has been suggested to be an important
this did not explain the observed differences in survival. determinant for both morbidity and mortality in uremic
One limitation of the current study was that only historic patients [22, 23]. Furthermore, a reduced dialysis dose
documentation of comorbid factors was used, and quan- has been shown to be associated with increased mortality
titative measures for the severity of these factors were across all causes of death [24]. Since Southeast Asian
not available. This may potentially limit our ability to and South Asian patients have a smaller body size and
detect whether the observed mortality differences could receive a higher average dialysis dose compared with
be related to different cardiovascular disease burden be- Caucasian and black patients (abstract; Pei et al, J Am
tween the racial groups. Future studies that incorporate Soc Nephrol 8:208, 1997), racial differences in the dialysis
quantitative measures of cardiovascular disease severity dose could be an important determinant for the observed
are needed to clarify this issue further.
findings. On the other hand, a large registry study has
Caucasian smokers with symptomatic cardiovascular
failed to document that dialysis dose influences patientdisease at the start of dialysis constitute a very high-
survival [25]. In addition to dialysis dose, the influencerisk group for increased mortality. The basis for this
of race-specific differences in diet and lifestyle may beobservation is also presently unknown. Another limita-
also important. All of these factors remain to be exploredtion of the current study is that quantitative data on
in future studies.cigarette smoking in the study patients were not avail-
In conclusion, we have documented an increased mor-able. Thus, we cannot exclude the possibility that the
tality risk in Caucasian patients with ESRD comparedmortality differences might have been related to racial
with three other racial groups, after adjusting for differ-differences in the cumulative dose of cigarette smoking,
ences in their comorbid risk factors. At this time, we arewith the whites being the heaviest smokers. However,
unable to determine whether these mortality differencesin a recent study of 144 healthy subjects without hyper-
may be in part related to differences in the cardiovasculartension, hyperlipidemia, and diabetes mellitus, white
disease burden between these racial groups. However,smokers were found to have an increased impairment
white smokers with symptomatic cardiovascular diseaseof arterial endothelial function compared with their Chi-
at the start of dialysis constitute a very high-risk groupnese counterparts when the dose of cigarette smoked
for increased mortality compared with smokers fromwas controlled [17]. These data suggest the possibility
other racial groups. While our study has focused on ure-for a race-specific differential susceptibility to cardiovas-
mic patients, racial differences in survival have beencular disease complications that may be related to envi-
documented in the general population as well [26]. It isronmental and/or genetic factors [17–21]. For example,
likely that both genetic and environmental factors mayracial differences in environmental factors such as di-
underlie these race-specific differences, but very little isetary fat and antioxidant intake could have an important
currently known about these factors. Future studies toimpact on cardiovascular disease mortality between the
elucidate these race-specific, gene-environmental deter-racial groups. However, comprehensive studies ad-
dressing the role of environmental factors on multiracial minants of health and disease are greatly needed.
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